M

Matricelf Ltd
TASE:MTLF

Watchlist Manager
Matricelf Ltd
TASE:MTLF
Watchlist
Price: 552.7 ILS 4.4% Market Closed
Market Cap: 151.9m ILS

Net Margin
Matricelf Ltd

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-18.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Matricelf Ltd
Glance View

Market Cap
151.9m ILS
Industry
Biotechnology

Matricelf Ltd. engages in research and development of technology in the field of regenerative medicine. The firm operates in the field of tissue engineering and regenerative medicine. The Firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The firm focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University.

MTLF Intrinsic Value
40.51 ILS
Overvaluation 93%
Intrinsic Value
Price
M
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-18.1m
/
Revenue
0
What is the Net Margin of Matricelf Ltd?

Based on Matricelf Ltd's most recent financial statements, the company has Net Margin of 0%.

Back to Top